Belite Bio, Inc (BLTE) Stock price, Description, News & Info

#Thinksabio latest news

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease